300. IgG4-related disease
31 clinical trials,   33 drugs   (DrugBank: 16 drugs),   11 drug target genes,   81 drug target pathways

Searched query = "IgG4-related disease", "Autoimmune pancreatitis", "IgG4-related sclerosing cholangitis", "IgG4-related lacrimal gland, orbital, and salivary gland lesions", "IgG4-related kidney disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04124861
(ClinicalTrials.gov)
October 15, 201913/2/2019Withdraw Drug in Stable IgG4-Related DiseaseEvaluation and Prediction of Relapse Risk After Glucocorticoid and Immunosuppressant Withdrawal in Patients With Stable IgG4 Related Disease: An Open-labeled Multi-centric Randomized Controlled Study From ChinaAutoimmune DiseasesDrug: Drug free, IS monotherapy and GC combined with ISPeking Union Medical College HospitalChinese PLA General Hospital;Peking University People's Hospital;The People's Hospital of Hebei Province;Shengjing Hospital;Tongji HospitalNot yet recruiting18 Years70 YearsAll138N/ANULL